Skip to content Skip to footer
A steadier labor market, cooler-than-expected inflation, fresh consumer purchasing power, evolving digital-advertising models and disciplined corporate cost management are creating a more constructive backdrop for equities. The economy is not behaving like a fireworks display, but for investors that may be the…
AbbVie Inc. (NYSE: ABBV) has secured (Sept. 28) FDA approval for JUVMO™ (tavapadon), a new once-daily Parkinson’s therapy, adding an important fresh option to a market long defined by the delicate art of managing motor symptoms, “OFF” time, dyskinesia and medication burden. For Serina…
NVIDIA Corp. (NASDAQ: NVDA) seemingly has given many a two-part bullish signal: a record-sized $150 billion increase to its share-repurchase authorization and a new AI-agent safety platform aimed at making autonomous software more secure for enterprise deployment. The combination suggests a company using…
Wall Street’s latest AI conversation is becoming less about clever chatbots and more about the decidedly unglamorous work of power, chips, networks, security and uptime. That shift may be constructive for investors: it broadens the AI opportunity from a small club of…
New York’s lawsuit against Polymarket U.S. is an obvious legal headache, but it may also accelerate the industry’s most valuable long-term asset: a clearer rulebook. For investors, operators, exchanges and market-infrastructure companies, the real story is not whether prediction markets face scrutiny,…